Quantitative Susceptibility Mapping
Also known as: QSM, susceptibility-weighted imaging
Quantitative Susceptibility Mapping (QSM) is a post-processing technique that converts MRI phase data into quantitative susceptibility values, enabling direct visualization and measurement of tissue magnetic properties. Developed by Wang, Liu, and colleagues, QSM transforms phase shifts caused by differences in magnetic susceptibility between tissues into tissue-specific biomarkers. It has revolutionized the sensitivity of MRI to iron, calcium, and other paramagnetic and diamagnetic substances, making it valuable in neurodegenerative disease diagnosis and tissue characterization.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
QSM is indicated when tissue iron, calcium, or other susceptibility-sensitive biomarkers are clinically relevant. It is most developed in neurology for detecting iron accumulation in basal ganglia diseases (Parkinson disease, multiple system atrophy, progressive supranuclear palsy) and for visualizing microbleeds and venous vasculature. QSM is emerging in cardiology (iron deposition in cardiomyopathy), orthopedics (cartilage calcification), and oncology (hemorrhage and necrosis in tumors). It requires high-field MRI (3T minimum, 7T preferred) and specialized post-processing expertise.
Strengths & limitations
- Quantitative tissue contrast: susceptibility is a tissue-specific physical property independent of flip angle, echo time, or sequence design, enabling standardized comparison across studies and sites
- High sensitivity to iron: 5-50 times more sensitive than R2 or R2* to iron concentration, enabling early detection of iron accumulation in neurodegeneration
- Morphological detail: venous vasculature, microbleeds, and microinfarcts are visualized with exceptional clarity in susceptibility maps
- Multisite reproducibility: robust algorithms and image processing pipelines enable multicenter trials with standardized susceptibility biomarkers
- Complementary to structural MRI: QSM provides non-overlapping information about tissue composition orthogonal to T1, T2, diffusion, or perfusion
- Model-dependent: susceptibility reconstruction depends on the choice of inverse algorithm, regularization, and prior assumptions; different methods can yield different results
- Background field removal error: imperfect removal of macroscopic field inhomogeneities (especially near air-tissue interfaces like sinuses) can contaminate susceptibility maps
- Partial volume averaging: voxels containing multiple tissue types yield mixed susceptibility values; fine structures (dopaminergic neurons, iron-laden cells) are blurred
- Computational demand: QSM processing is time-consuming and requires specialized software and expertise; not yet standardized across vendors or sites
- Limited clinical validation: QSM is not yet routine in clinical practice; thresholds for diagnosis and prognosis are still being established
Frequently asked
What is the difference between QSM and susceptibility-weighted imaging (SWI)?
SWI is a qualitative imaging technique that combines magnitude and phase to enhance susceptibility contrast, especially for venous vasculature and microbleeds. QSM is a quantitative post-processing method that solves the inverse problem to recover absolute susceptibility values. QSM images are easier to interpret quantitatively and compare across studies; SWI is qualitatively superior for visual detection of small hemorrhages.
What is the COSMOS algorithm, and why is it important?
COSMOS (Calculation of Susceptibility through Multiple Orientation Sampling) solves the inverse problem by acquiring phase data at multiple head orientations relative to the main magnetic field. Each orientation provides independent information about tissue susceptibility. COSMOS is considered the gold standard because it requires minimal assumptions and directly reconstructs susceptibility without regularization bias. However, it requires multiple acquisitions.
Can QSM be performed on 1.5T or 3T MRI, or is 7T required?
QSM can be performed at 3T, though signal-to-noise and phase contrast are better at 7T. At 3T, QSM is feasible for larger structures (basal ganglia); at 7T, smaller or lower-iron regions are accessible. Field strength choice depends on the clinical question and available resources. Most published clinical QSM work is at 3T; 7T studies focus on fine anatomical detail.
How is background field removal performed, and why is it critical?
Background field is the macroscopic non-local field inhomogeneity from object geometry and air-tissue interfaces. SHARP, VSHARP, and related algorithms estimate and subtract it using spherical harmonic decomposition or harmonic filtering. Imperfect removal creates artifacts near brain boundaries. Critical regions like the cortex and near-ventricle basal ganglia voxels are prone to residual background artifact.
What are typical susceptibility values in the brain, and what indicates pathology?
Normal iron-rich structures like substantia nigra and red nucleus have susceptibility around 0.05-0.15 ppm. Pathologic iron accumulation in Parkinson or MSA can elevate this 20-50%. Calcifications are diamagnetic (negative susceptibility). Acute blood (oxyhemoglobin) is nearly diamagnetic; chronic blood (hemosiderin) is highly paramagnetic. Clinical thresholds are still being validated; normative databases across age and sex are developing.
Sources
- Wang, Y., Liu, T. (2015). Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker. Magnetic Resonance in Medicine, 73(1), 82-101. DOI: 10.1002/mrm.25358 ↗
- Liu, T., Spincemaille, P., de Rochefort, L., et al. (2009). Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from undersample phase data. Magnetic Resonance in Medicine, 66(3), 579-592. link ↗
- Haacke, E. M., Xu, Y., Cheng, Y. C., Reichenbach, J. R. (2004). Susceptibility weighted imaging (SWI). Magnetic Resonance in Medicine, 52(3), 612-618. DOI: 10.1002/mrm.20198 ↗
How to cite this page
ScholarGate. (2026, June 3). Quantitative Susceptibility Mapping. ScholarGate. https://scholargate.app/en/medical-imaging/quantitative-susceptibility-mapping
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- CT Iterative ReconstructionMedical Imaging↔ compare
- DTI TractographyMedical Imaging↔ compare
- Functional UltrasoundMedical Imaging↔ compare
- OCT AngiographyMedical Imaging↔ compare
- PET Kinetic ModelingMedical Imaging↔ compare